ArticleFEBS open bio2019

Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment.

Agnieszka Korga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.